Identification of a gene expression signature for survival prediction in type I endometrial carcinoma

Gene Expression

Volumn 14, Issue 6, 2010, Pages 361-370

  Levan, Kristina ^a   Partheen, Karolina ^a   Österberg, Lovisa ^a   Olsson, Björn ^b   Delle, Ulla ^a   Eklind, Saskia ^a   Horvath, György ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF SKÖVDE   (Sweden)

Author keywords

Endometrial cancer; Expression array; Survival

Indexed keywords

PROTEIN MSH2; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F2;

ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CELL CYCLE REGULATION; CLINICAL ARTICLE; CLUSTER ANALYSIS; ENDOMETRIOID CARCINOMA; EXO1 GENE; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; MYCN GENE; PROGNOSIS; STUDENT T TEST;

EID: 77954889112     PISSN: 10522166     EISSN: None     Source Type: Journal    
DOI: 10.3727/105221610X12735213181242     Document Type: Article

References (27)

1. Bair, E.; Tibshirani, R. Semi-supervised methods to predict patient survival from gene expression data. PLoS Biol. 2:E108; 2004.
2. Cao, Q. J.; Belbin, T.; Socci, N.; Balan, R.; Prystowsky, M. B.; Childs, G.; Jones, J. G. Distinctive gene expression profiles by cDNA microarrays in endometrioid and serous carcinomas of the endometrium. Int. J. Gynecol. Pathol. 23:321-329; 2004.
3. Caraux, G.; Pinloche, S. PermutMatrix: A graphical environment to arrange gene expression profiles in optimal linear order. Bioinformatics 21:1280-1281; 2005.
4. Demiroz, G.; Guvenir, H. A. Classification by voting feature intervals. In: Lecture notes in computer science, vol. 1224. Berlin: Springer; 1997.
5. Ferguson, S. E.; Olshen, A. B.; Viale, A.; Awtrey, C. S.; Barakat, R. R.; Boyd, J. Gene expression profiling of tamoxifen-associated uterine cancers: Evidence for two molecular classes of endometrial carcinoma. Gynecol. Oncol. 92:719-725; 2004.
6. Frank, E.; Hall, M.; Trigg, L.; Holmes, G.; Witten, I. H. Data mining in bioinformatics using Weka. Bioinformatics 20:2479-2481; 2004.
7. Gehan, E. A. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 52: 203-223; 1965.
8. Hogberg, T. Adjuvant chemotherapy in endometrial carcinoma: Overview of randomised trials. Clin. Oncol. (R Coll. Radiol.) 20:463-469; 2008.
9. Ito, K. Hormone replacement therapy and cancers: The biological roles of estrogen and progestin in tumorigenesis are different between the endometrium and breast. Tohoku J. Exp. Med. 212:1-12; 2007.
10. Jadoul, P.; Donnez, J. Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma. Fertil. Steril. 80:1315-1324; 2003.
11. Lax, S. F. Molecular genetic pathways in various types of endometrial carcinoma: From a phenotypical to a molecular-based classification. Virchows Arch. 444: 213-223; 2004.
12. Leone, G.; DeGregori, J.; Yan, Z.; Jakoi, L.; Ishida, S.; Williams, R. S.; Nevins, J. R. E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev. 12:2120-2130; 1998.
13. Levan, K.; Partheen, K.; Osterberg, L.; Helou, K.; Horvath, G. Chromosomal alterations in 98 endometrioid adenocarcinomas analyzed with comparative genomic hybridization. Cytogenet. Genome Res. 115:16-22; 2006.
14. Liu, F. S. Molecular carcinogenesis of endometrial cancer. Taiwan J. Obstet. Gynecol. 46:26-32; 2007.
15. Moreno-Bueno, G.; Sanchez-Estevez, C.; Cassia, R.; Rodriguez-Perales, S.; Diaz-Uriarte, R.; Dominguez, O.; Hardisson, D.; Andujar, M.; Prat, J.; Matias-Guiu, X.; Cigudosa, J. C.; Palacios, J. Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas. Cancer Res. 63:5697-5702; 2003. (Pubitemid 37187463)
16. Nevins, J. R. The Rb/E2F pathway and cancer. Hum. Mol. Genet. 10:699-703; 2001.
17. Partheen, K.; Levan, K.; Osterberg, L.; Horvath, G. Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors. Eur. J. Cancer 42:2846-2854; 2006. (Pubitemid 44584671)
18. Risinger, J. I.; Maxwell, G. L.; Chandramouli, G. V.; Jazaeri, A.; Aprelikova, O.; Patterson, T.; Berchuck, A.; Barrett, J. C. Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer. Cancer Res. 63:6-11; 2003.
19. Saal, L. H.; Troein, C.; Vallon-Christersson, J.; Gruvberger, S.; Borg, A.; Peterson, C. BioArray Software Environment (BASE): A platform for comprehensive management and analysis of microarray data. Genome Biol. 3:SOFTWARE0003; 2002.
20. Samuelson, E.; Levan, K.; Adamovic, T.; Levan, G.; Horvath, G. Recurrent gene amplifications in human type I endometrial adenocarcinoma detected by fluorescence in situ hybridization. Cancer Genet. Cytogenet. 181:25-30; 2008.
21. Simard, J.; de Launoit, Y.; Haagensen, D. E.; Labrie, F. Additive stimulatory action of glucocorticoids and androgens on basal and estrogen-repressed apolipoprotein-D messenger ribonucleic acid levels and secretion in human breast cancer cells. Endocrinology 130: 1115-1121; 1992.
22. Socialstyrelsen. Cancer incidence in Sweden 2006. Stockholm: Statistics, Sweden; 2007.
23. Sorbe, B.; Horvath, G.; Andersson, H.; Boman, K.; Lundgren, K.; Pettersson, B. External pelvic and vaginal irradiation versus vaginal irradiation alone as post-operative therapy in medium risk endometrial carcinoma - a prospective randomized study. Abstract, IGCS Meeting, Bangkok; 2008.
24. Still, I. H.; Hamilton, M.; Vince, P.; Wolfman, A.; Cowell, J. K. Cloning of TACC1, an embryonically expressed, potentially transforming coiled coil containing gene, from the 8p11 breast cancer amplicon. Oncogene 18:4032-4038; 1999.
25. Sugiyama, Y.; Dan, S.; Yoshida, Y.; Akiyama, F.; Sugiyama, K.; Hirai, Y.; Matsuura, M.; Miyata, S.; Ushijima, M.; Hasutni, K.; Yamori, T. A large-scale gene expression comparison of microdissected, small-sized endometrial cancers with or without hyperplasia matched to same-patient normal tissue. Clin. Cancer Res. 9:5589-5600; 2003.
26. Wong, Y. F.; Cheung, T. H.; Lo, K. W.; Yim, S. F.; Siu, N. S.; Chan, S. C.; Ho, T. W.; Wong, K. W.; Yu, M. Y.; Wang, V. W.; Li, C.; Gardner, G. J.; Bonome, T.; Johnson, W. B.; Smith, D. I.; Chung, T. K.; Birrer, M. J. Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling. Oncogene 26:1971-1982; 2007.
27. Yang, Y. H.; Dudoit, S.; Luu, P.; Lin, D. M.; Peng, V.; Ngai, J.; Speed, T. P. Normalization for cDNA microarray data: A robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30:e15; 2002.